Fate Therapeutics Rallies 10.8% Amid Volatility, Outpacing Regenerative Peers
Fate Therapeutics (FATE) jumps 10.75% amid volatile biotech markets—discover why the stem‑cell company’s rally could signal fresh growth prospects.
- FATE THERAPEUTICS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read